Urinary Eicosanoid Metabolites in HIV-Infected Women with Central Obesity Switching to Raltegravir: An Analysis from the Women, Integrase, and Fat Accumulation Trial
Figure 2
Median baseline and 24-week urinary eicosanoid levels by study arm. Between-group value <0.1–0.05; between-group value <0.05. Panel (a) shows F2-IsoP; Panel (b) shows PGE-M (baseline and week 24 between-group ); Panel (c) shows PGI-M (baseline between-group , week 24 between-group , and between-group 24-week change ); Panel (d) shows TxB2 (baseline between-group and between-group 24-week change ). F2-IsoPs: F2-isoprostanes; PGE-M: prostaglandin E2 metabolite; PGI-M: prostacyclin metabolite; TxB2: thromboxane B2. Units are ng/mg creatinine.
